|
Volumn 96, Issue 3, 2002, Pages 329-333
|
Interleukin (il)-6, il-8 and il-10 in serum and csf of trypanosoma brucei gambiense sleeping sickness patients before and after treatment
|
Author keywords
Cerebrospinal fluid; Chemotherapy; Cytokines; DR Congo; Interferon gamma; Interleukin 10; Interleukin 6; Interleukin 8; Serum; Trypanosoma brucei gambiense; Trypanosomiasis; Tumour necrosis factor alpha
|
Indexed keywords
GAMMA INTERFERON;
INTERLEUKIN 10;
INTERLEUKIN 6;
INTERLEUKIN 8;
MELARSOPROL;
NIFURTIMOX;
SURAMIN;
TUMOR NECROSIS FACTOR ALPHA;
ADOLESCENT;
ADULT;
AFRICAN TRYPANOSOMIASIS;
ARTICLE;
BLOOD LEVEL;
CELL COUNT;
CEREBROSPINAL FLUID LEVEL;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONGO;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
FEMALE;
HUMAN;
MALE;
STAGING;
TRYPANOSOMA;
ADOLESCENT;
ADULT;
ANALYSIS OF VARIANCE;
DRUG COMBINATIONS;
ENZYME-LINKED IMMUNOSORBENT ASSAY;
FEMALE;
HUMANS;
INTERFERON TYPE II;
INTERLEUKIN-10;
INTERLEUKIN-6;
INTERLEUKIN-8;
INTERLEUKINS;
MALE;
MELARSOPROL;
MIDDLE AGED;
NIFURTIMOX;
TRYPANOCIDAL AGENTS;
TRYPANOSOMIASIS, AFRICAN;
TUMOR NECROSIS FACTOR-ALPHA;
PROTOZOA;
TRYPANOSOMA;
TRYPANOSOMA BRUCEI;
TRYPANOSOMA BRUCEI GAMBIENSE;
|
EID: 0036061683
PISSN: 00359203
EISSN: None
Source Type: Journal
DOI: 10.1016/S0035-9203(02)90115-X Document Type: Article |
Times cited : (65)
|
References (18)
|